You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 122 No. 5, May 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  COMMENTARY
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (45)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Behçet's Disease

An Update Based on the 1985 International Conference in London

Joseph L. Jorizzo, MD

Arch Dermatol. 1986;122(5):556-558.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

This commentary provides an overview of recent advances concerning Behçet's disease based on proceedings of the international conference on Behçet's disease sponsored by the Royal Society of Medicine and held at the Royal College of Physicians in London on Sept 5 and 6,1985.1I have been liberal in giving my opinions, but I also identify the presenters.

This unique conference is held at four-year intervals and brings together physicians from many disciplines to discuss new advances in treating Behçet's disease. Authors from 20 countries presented 100 abstracts during this meticulously orchestrated event. Professors Hoffenberg, president of the Royal College of Physicians, and Lehner, chairman of the Scientific Committee, made introductory remarks. I have followed the conference's grouping in presenting highlights and my opinions.

IMMUNOLOGY, GENETICS, AND ETIOLOGIC AGENTS

Disease susceptibility genes studied in large independent Japanese and British surveys appear to be HLA-B51 and HLA-DRw52. In addition, there is . . . [Full Text PDF of this Article]


Author Affiliations

From the Department of Dermatology, University of Texas Medical Branch, Galveston. Dr Jorizzo is now with the Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC.


Footnotes

Accepted for publication Jan 17, 1986.

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.